SCHEMBL29071979

SCHEMBL29071979

CC(C)(C)OC(=O)Nc1cc(Br)c(F)cc1C=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 5/20 0.46
CYP17A1 P05093 1/20 0.39
RXFP1 Q9HBX9 1/20 0.36
KCNQ4 P56696 1/20 0.35
KCNQ5 Q9NR82 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
RECQL P46063 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ERN1 O75460 1/20 0.35
BRAF P15056 1/20 0.34
MEN1 O00255 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34
IDO1 P14902 1/20 0.34
LCK P06239 3/20 0.33
HDAC3 O15379 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29393116 1.00 AAK1 (0.46) AAK1CYP17A1RXFP1KCNQ4KCNQ5
SCHEMBL29952152 0.88 CYP17A1 (0.42) AAK1CYP17A1RXFP1KCNQ4KCNQ5
SCHEMBL31736070 0.82 AAK1 (0.52) AAK1CYP17A1RXFP1KCNQ4KCNQ5
SCHEMBL25159676 0.82 AAK1 (0.46) AAK1CYP17A1RXFP1KCNQ4KCNQ5
SCHEMBL29395253 0.82 AAK1 (0.46) AAK1CYP17A1RXFP1KCNQ4KCNQ5
SCHEMBL29954656 0.80 KCNQ4 (0.46) CYP17A1RXFP1KCNQ4KCNQ5HTT
SCHEMBL29071965 0.80 AAK1 (0.45) AAK1CYP17A1RXFP1KCNQ4KCNQ5
SCHEMBL29071984 0.80 AAK1 (0.47) AAK1CYP17A1RXFP1KCNQ4KCNQ5
SCHEMBL29393326 0.80 AAK1 (0.47) AAK1CYP17A1RXFP1KCNQ4KCNQ5
SCHEMBL12121804 0.79 HDAC1 (0.43) RXFP1NPC1RAB9ASMN1; SMN2ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116745269-A Dihydroquinazolin-2-one derivatives as selective cytotoxic agents for the treatment of HIV 默沙东有限责任公司 2023-09-12 CN disclosed